As part of the healthcare overhaul under consideration by Congress, lawmakers have included provisions intended to shed light on the financial relationships between the medical industry and doctors. The targets are common business practices like drug company payments to doctors for speeches and consulting services, which have the potential to influence patient care and increase medical bills. But if previous attempts by state legislatures, federal agencies, and academic hospitals are any indication, such efforts are all too vulnerable, the New York Times reports.
